Bedside Rounds

Lower GI bleed: workup and management

Acute lower GI bleeding presents with hematochezia. Resuscitate, exclude an upper GI source in hemodynamically unstable patients, risk-stratify (e.g., Oakland score), and arrange colonoscopy after bowel prep. CT angiography is the first test for ongoing brisk bleeding.

Working diagnosis Adult · US guidelines Draft · awaiting physician review
Tailor to a patient with AI Bedside calculators Report an error

01Orient

What's new in the evidence

  • ACG 2023 guideline: urgent colonoscopy within 24 hours is no longer routine; trials showed no benefit, so use the next available inpatient slot
  • CT angiography first for hemodynamically unstable hematochezia; refer positive scans promptly for embolization
  • Reverse anticoagulation only for life-threatening bleeding that does not respond to resuscitation; resume anticoagulation, usually within 7 days
  • Oakland score ≤8 supports discharge with outpatient evaluation

Differential diagnoses

  1. Diverticular bleeding
  2. Brisk upper GI bleed (can't miss: 10–15% of severe hematochezia)
  3. Angiodysplasia
  4. Ischemic colitis
  5. Colorectal cancer or polyp, post-polypectomy bleed
  6. Hemorrhoids or anal fissure
  7. Inflammatory or infectious colitis

02Assess

Risk scores and decision tools

  • Oakland score (≤8: safe for discharge)
  • Shock index (HR/SBP >1 suggests significant bleeding)
  • BUN:creatinine ratio >30 suggests an upper source

Key history questions

  • Volume, color and frequency of bleeding; syncope
  • Antiplatelets, anticoagulants, NSAIDs
  • Recent polypectomy, prior diverticular bleeding
  • Weight loss, change in bowel habit
  • Abdominal pain (ischemia, colitis)
  • Cardiovascular disease and cirrhosis

Examination findings

  • Heart rate, blood pressure, orthostatics
  • Abdominal tenderness
  • Digital rectal exam and anoscopy for blood, masses, hemorrhoids

03Investigate

Initial investigations

  • CBC, BMP (BUN:creatinine ratio >30 suggests upper source), INR
  • Type and screen or crossmatch
  • Oakland score for discharge decisions

Advanced investigations

  • Colonoscopy after bowel preparation at the next available inpatient slot; urgent (<24 h) colonoscopy has not improved outcomes
  • CT angiography first for ongoing hemodynamically significant bleeding, then catheter angiography and embolization
  • Upper endoscopy for hemodynamic instability or high BUN ratio

04Treat

Immediate management

  • Two large-bore IVs and crystalloid
  • Transfuse to hemoglobin ≥7 g/dL (≥8 g/dL with cardiovascular disease)
  • Hold anticoagulants; reverse for life-threatening bleeding
  • Unstable with suspected ongoing bleeding: CT angiography first

First-line treatment

  • Colonoscopy with endoscopic hemostasis (clips, epinephrine, thermal)
  • Continue aspirin for secondary cardiovascular prevention when possible
  • Stop NSAIDs

Second-line treatment

  • Angiographic embolization for bleeding seen on CTA
  • Surgery for refractory bleeding after localization

Specialist referrals

  • Gastroenterology
  • Interventional radiology for positive CTA
  • Colorectal surgery for refractory bleeding

05Disposition

Admission criteria

  • Oakland score >8
  • Hemodynamic instability, ongoing bleeding, transfusion need
  • Anticoagulation or significant comorbidity

Safe discharge criteria

  • Oakland score ≤8 with stable vitals and hemoglobin
  • Outpatient colonoscopy arranged

Follow-up timing

  • Repeat CBC within 1 week; outpatient colonoscopy if not done

Patient instructions

  • Avoid NSAIDs
  • Return for further bleeding, dizziness or fainting

Monitoring

  • Serial hemoglobin every 6–12 hours initially
  • Vital signs

Clinical pearls and pitfalls

  • Most diverticular bleeding stops spontaneously but recurs in up to 20–40%
  • Restart anticoagulation once hemostasis is achieved, after weighing thrombotic risk

RefGuidelines and landmark evidence

For education only. Typical adult starting points; confirm doses against renal function, allergies, interactions and your institution's protocols. Not a substitute for clinical judgment or senior review.